blockbuster drug


Also found in: Wikipedia.

blockbuster drug

A drug that generates more than a billion dollars in sales.
Mentioned in ?
References in periodicals archive ?
Humira[TM], the first fully human recombinant antibody for the treatment of rheumatoid arthritis by Abbott Laboratories and CAT already became a blockbuster drug within the third year of its introduction into the market reaching sales of $1.
Earlier this month, Amgen stopped a late-stage trial of a potentially blockbuster drug to treat Lou Gehrig's disease when testing showed it was ineffective.
has sued to force the Food and Drug Administration to speed up the introduction of generic versions of Pfizer's blockbuster drug Lipitor (atorvastatin).
2010, SPA -- Federal health authorities are recommending the blockbuster drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug&'s original promise to help slow the disease.
Significance of the deal lies in potential of Caerulomycin to develop into a blockbuster drug to be used to prevent organ transplantation rejection and diseases such as certain autoimmune disorders where immunosuppression is the key to the mitigation of the symptoms.
Analysts are backing it to become the first blockbuster drug of the 21st century, New Scientist magazine said.
Elan needs to have a blockbuster drug come out of research and development or through acquisition," he explains.
How humans feel about their social and economic status may have as great a health impact as a breakthrough treatment or blockbuster drug, according to British epidemiologist Richard Wilkinson.
Thousand Oaks-based Amgen is poised to announce that its blockbuster drug Aranesp can be administered only once a month to maintain healthy hemoglobin levels.
com/research/3c14b2/successes_and_fail) has announced the addition of GlobalData 's new report "Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market" to their offering.
April 25 /PRNewswire/ -- The obstacles to success in the pharmaceutical industry are growing more numerous and complicated as the blockbuster drug is becoming an increasingly unattainable goal.